Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia'. Together they form a unique fingerprint.

Medicine & Life Sciences